179 related articles for article (PubMed ID: 1732112)
1. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.
Hecht G; Koutsouris A; Pothoulakis C; LaMont JT; Madara JL
Gastroenterology; 1992 Feb; 102(2):416-23. PubMed ID: 1732112
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.
Hecht G; Pothoulakis C; LaMont JT; Madara JL
J Clin Invest; 1988 Nov; 82(5):1516-24. PubMed ID: 3141478
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function.
Hopkins AM; Walsh SV; Verkade P; Boquet P; Nusrat A
J Cell Sci; 2003 Feb; 116(Pt 4):725-42. PubMed ID: 12538773
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
5. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment.
Mahida YR; Makh S; Hyde S; Gray T; Borriello SP
Gut; 1996 Mar; 38(3):337-47. PubMed ID: 8675084
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of Clostridium difficile toxin-induced damage to epithelial barrier by ecto-5'-nucleotidase (CD73) and adenosine receptor signaling.
Schenck LP; Hirota SA; Hirota CL; Boasquevisque P; Tulk SE; Li Y; Wadhwani A; Doktorchik CT; Macnaughton WK; Beck PL; MacDonald JA
Neurogastroenterol Motil; 2013 Jun; 25(6):e441-53. PubMed ID: 23600886
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
8. C. difficile toxin A increases intestinal permeability and induces Cl- secretion.
Moore R; Pothoulakis C; LaMont JT; Carlson S; Madara JL
Am J Physiol; 1990 Aug; 259(2 Pt 1):G165-72. PubMed ID: 2116728
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile toxins may augment bacterial penetration of intestinal epithelium.
Feltis BA; Kim AS; Kinneberg KM; Lyerly DL; Wilkins TD; Erlandsen SL; Wells CL
Arch Surg; 1999 Nov; 134(11):1235-41; discussion 1241-2. PubMed ID: 10555639
[TBL] [Abstract][Full Text] [Related]
11. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
12. Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells.
Gerhard R; Schmidt G; Hofmann F; Aktories K
Infect Immun; 1998 Nov; 66(11):5125-31. PubMed ID: 9784513
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L.
Ciesielski-Treska J; Ulrich G; Baldacini O; Monteil H; Aunis D
Eur J Cell Biol; 1991 Oct; 56(1):68-78. PubMed ID: 1724754
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
[TBL] [Abstract][Full Text] [Related]
16. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
Stubbe H; Berdoz J; Kraehenbuhl JP; Corthésy B
J Immunol; 2000 Feb; 164(4):1952-60. PubMed ID: 10657645
[TBL] [Abstract][Full Text] [Related]
17. Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro.
Chambers FG; Koshy SS; Saidi RF; Clark DP; Moore RD; Sears CL
Infect Immun; 1997 Sep; 65(9):3561-70. PubMed ID: 9284120
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers.
Hofman P; Flatau G; Selva E; Gauthier M; Le Negrate G; Fiorentini C; Rossi B; Boquet P
Infect Immun; 1998 Jun; 66(6):2494-500. PubMed ID: 9596707
[TBL] [Abstract][Full Text] [Related]
19. ADP-ribosylation in Clostridium difficile toxin-treated cells is not related to cytopathogenicity of toxin B.
Florin I; Thelestam M
Biochim Biophys Acta; 1991 Jan; 1091(1):51-4. PubMed ID: 1995067
[TBL] [Abstract][Full Text] [Related]
20. Human intestinal epithelial cells swell and demonstrate actin rearrangement in response to the metalloprotease toxin of Bacteroides fragilis.
Koshy SS; Montrose MH; Sears CL
Infect Immun; 1996 Dec; 64(12):5022-8. PubMed ID: 8945541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
